About BLACK CANYON BIO. INC.
Black Canyon Bio, Inc. is developing novel cancer treatments using its proprietary Specific Neo-Antigen Peptides (SNAP) Technology platform, focusing on advanced precision therapies for cancer immunotherapy.
Development of novel cancer treatmentsProprietary Specific Neo-Antigen Peptides (SNAP) Technology platformCreation of therapeutic cancer vaccines such as SNAPduo 101
Is this your company?
Claim BLACK CANYON BIO. INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim BLACK CANYON BIO. INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.